Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password
PMLiVE Top Pharma List

Shionogi

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shionogi's 2012 Japan sales performance.

Shionogi & Co., Ltd.

ViiV maintains top spot in reputation survey

ViiV maintains top spot in reputation survey Shionogi came out top.

GSK hints at more restructuring following income drop

GSK hints at more restructuring following income drop Chief executive Sir Andrew Witty said GSK is considering a spin-out with its HIV joint venture with Pfizer and Shionogi – ViiV Healthcare – and is also open to other deals that

Germany gives green light to Viiv's Triumeq for HIV

Germany gives green light to Viiv's Triumeq for HIV Viiv - set up in 2009 as a partnership between GSK and Pfizer and joined by Shionogi in 2012 - is hoping Triumeq will make inroads into Gilead Sciences' dominant position in the

BioCryst gets FDA nod for first intravenous flu drug

BioCryst gets FDA nod for first intravenous flu drug Rapivab has been on the market since 2010 in Japan and South Korea - where it is sold as Rapiacta by licensee Shionogi - but it will be BioCryst's first commercialised product.

Cancer drugs lead SMC recommendations

Cancer drugs lead SMC recommendations Triumeq is a combination of dolutegravir, abacavir and lamivudine developed by ViiV Healthcare, a partnership between Pfizer, GSK and Shionogi.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Global Data

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology

Subscribe to our email news alerts

PMHub

Add my company
Wiley

Wiley is a global leader in research and education. We’ve spent more than 200 years developing resources for college, career,...

Latest intelligence

The 17th World Congress on Controversies in Neurology
This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...

Quick links